Serum glycoproteins in pulmonary tuberculosis

Area of Science:

• Biochemistry
• Clinical Medicine
• Pulmonology

Background:

• Pulmonary tuberculosis (TB) is a significant global health concern.
• Biochemical markers can aid in understanding disease activity and progression.
• Serum glycoproteins are implicated in various inflammatory and infectious diseases.

Purpose of the Study:

• To investigate serum glycoprotein levels in patients with pulmonary tuberculosis.
• To compare these levels with those in healthy controls.
• To assess the impact of disease stage and treatment on glycoprotein concentrations.

Main Methods:

• Serum samples were collected from 50 pulmonary tuberculosis patients and 25 healthy controls.
• Levels of protein-bound hexose, hexosamine, fucose, and sialic acid were quantified.
• Patients were categorized by disease stage (I, II, III) and presence of effusion.
• Erythrocyte Sedimentation Rate (ESR) and glycoprotein levels were monitored during antituberculosis treatment.

Main Results:

• Significantly higher serum levels of protein-bound hexose, hexosamine, fucose, and sialic acid were observed in TB patients compared to controls (P < 0.001).
• Glycoprotein levels increased across all stages of pulmonary tuberculosis.
• Antituberculosis treatment led to a decrease in ESR and glycoprotein levels, but levels did not normalize to control ranges.
• Age and sex did not influence glycoprotein levels in either group.

Conclusions:

• Elevated serum glycoprotein levels are a characteristic biochemical finding in pulmonary tuberculosis.
• These markers reflect disease activity and may not fully normalize even after standard treatment.
• Further research into the role and therapeutic targeting of these glycoproteins in TB is warranted.